I

IM Cannabis Corp
NASDAQ:IMCC

Watchlist Manager
IM Cannabis Corp
NASDAQ:IMCC
Watchlist
Price: 1.36 USD -1.45% Market Closed
Market Cap: 3m USD

Net Margin

-8.6%
Current
Improving
by 105.4%
vs 3-y average of -114%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8.6%
=
Net Income
CA$-4.7m
/
Revenue
CA$54.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-8.6%
=
Net Income
$-4.7m
/
Revenue
CA$54.5m

Peer Comparison

Country Company Market Cap Net
Margin
CA
IM Cannabis Corp
CNSX:IMCC
9.7m CAD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...

Market Distribution

In line with most companies in Canada
Percentile
49th
Based on 4 909 companies
49th percentile
-8.6%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

IM Cannabis Corp
Glance View

Market Cap
3m USD
Industry
Pharmaceuticals

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company is headquartered in Vancouver, British Columbia and currently employs 283 full-time employees. The firm operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), where it cultivates, imports and distributes cannabis to medical patients, data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel. The firm operates in Germany through Adjupharm GmbH (Adjupharm), where it is a certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses. The firm operates in Canada through Trichome JWC Acquisition Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

IMCC Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-8.6%
=
Net Income
CA$-4.7m
/
Revenue
CA$54.5m
What is IM Cannabis Corp's current Net Margin?

The current Net Margin for IM Cannabis Corp is -8.6%, which is above its 3-year median of -114%.

How has Net Margin changed over time?

Over the last 3 years, IM Cannabis Corp’s Net Margin has increased from -34.9% to -8.6%. During this period, it reached a low of -347.6% on Dec 31, 2022 and a high of -8.6% on Apr 3, 2025.

Back to Top